383 related articles for article (PubMed ID: 19887275)
21. Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade.
Schaller SJ; Lewald H
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1097-108. PubMed ID: 27463265
[TBL] [Abstract][Full Text] [Related]
22. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.
de Boer HD; van Esmond J; Booij LH; Driessen JJ
Paediatr Anaesth; 2009 Dec; 19(12):1226-8. PubMed ID: 19863737
[TBL] [Abstract][Full Text] [Related]
23. Urgent usage of sugammadex to treat residual neuromuscular blockade in the PACU.
Jones PM; Turkstra TP
Anesth Analg; 2007 Sep; 105(3):877; author reply 878. PubMed ID: 17717257
[No Abstract] [Full Text] [Related]
24. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
[TBL] [Abstract][Full Text] [Related]
25. [Extremely prolonged neuromuscular block after a single dose of rocuronium].
Menouni O; Brillouet-Banchereau AC; Galan G; Lélias A; Sautereau A; Gadrey S
Ann Fr Anesth Reanim; 2011 Nov; 30(11):841-3. PubMed ID: 21983058
[TBL] [Abstract][Full Text] [Related]
26. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients.
McDonagh DL; Benedict PE; Kovac AL; Drover DR; Brister NW; Morte JB; Monk TG
Anesthesiology; 2011 Feb; 114(2):318-29. PubMed ID: 21239968
[TBL] [Abstract][Full Text] [Related]
27. Emergency use of sugammadex after failure of standard reversal drugs.
Lenz A; Hill G; White PF
Anesth Analg; 2007 Mar; 104(3):585-6. PubMed ID: 17312213
[TBL] [Abstract][Full Text] [Related]
28. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
Carron M; Zarantonello F; Tellaroli P; Ori C
J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
[TBL] [Abstract][Full Text] [Related]
30. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
[TBL] [Abstract][Full Text] [Related]
31. Case report: sugammadex used to successfully reverse vecuronium-induced neuromuscular blockade in a 7-month-old infant.
Buchanan CC; O'Donnell AM
Paediatr Anaesth; 2011 Oct; 21(10):1077-8. PubMed ID: 21981096
[No Abstract] [Full Text] [Related]
32. Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic-pharmacodynamic modelling approach.
Zwiers A; van den Heuvel M; Smeets J; Rutherford S
Clin Drug Investig; 2011; 31(2):101-11. PubMed ID: 21067251
[TBL] [Abstract][Full Text] [Related]
33. Do we really need sugammadex as an antagonist of muscle relaxants in anesthesia?
Meistelman C; Donati F
Curr Opin Anaesthesiol; 2016 Aug; 29(4):462-7. PubMed ID: 27168088
[TBL] [Abstract][Full Text] [Related]
34. The use of sugammadex in a patient with myasthenia gravis.
Unterbuchner C; Fink H; Blobner M
Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
[TBL] [Abstract][Full Text] [Related]
35. [Sugammadex reversal of neuromuscular blockade for thymectomy in a patient with myasthenia gravis].
Monsalve Naharro JA; Gerónimo Pardo M; Ortiz Sánchez VE; Pérez Valdivieso JM
Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):624-5. PubMed ID: 22263413
[No Abstract] [Full Text] [Related]
36. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
Nicholson WT; Sprung J; Jankowski CJ
Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
[TBL] [Abstract][Full Text] [Related]
37. Was it a true emergency?
Ziser A
Anesth Analg; 2007 Sep; 105(3):876-7; author reply 878. PubMed ID: 17717254
[No Abstract] [Full Text] [Related]
38. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
39. The Use of Sugammadex in a Patient With Guillain-Barre Syndrome: A Case Report.
Tezcan B; Bölükbaşi D; Kazanci D; Turan S; Suer Kaya G; Özgök A
A A Case Rep; 2017 Apr; 8(8):200-202. PubMed ID: 28151766
[TBL] [Abstract][Full Text] [Related]
40. Pseudo-emergent use of an investigational drug.
Rosman EJ
Anesth Analg; 2007 Sep; 105(3):876; author reply 876, 878. PubMed ID: 17717255
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]